Mayo Clinic recently announced the first stem cell-based clinical trial for congenital heart disease. The clinical trial aims to determine how stem cells derived from autologous umbilical cord blood can help children with Hypoplastic Left Heart Syndrome, a rare defect where the left side of the heart is critically underdeveloped.
Read the full news release and watch a video describing the research:
Tags: HLHS, Mayo Clinic, News, research, Research, stem cells, Timothy Nelson